Hamelin Paul 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Jun 26, 2008
Insider Transaction Report
Form 4
Hamelin Paul
President
Transactions
- Sale
Common Stock, $.01 par value per share
2008-05-23$24.09/sh−1,232$29,679→ 38,419 total - Sale
Common Stock, $.01 par value per share
2008-06-24$25.25/sh−1,231$31,083→ 38,419 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2008-06-24$5.11/sh−1,231$6,290→ 38,769 totalExercise: $5.11From: 2007-05-23Exp: 2016-05-23→ Common Stock, $.01 par value per share (1,231 underlying) - Exercise/Conversion
Common Stock, $.01 par value per share
2008-06-24$5.11/sh+1,231$6,290→ 39,650 total
Footnotes (3)
- [F1]Late filing due to administrative error by Service Provider.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on May 23, 2006.
- [F3]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.